Redhill Biopharma Ltd. sell Marianka
Start price
28.11.23
/
60%
€1.76
Target price
28.11.24
€0.000
Performance (%)
-28.50%
End price
09.12.23
€1.26
Summary
This prediction ended on 09.12.23 with a price of €1.26. The price of Redhill Biopharma Ltd. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -28.50%. Marianka has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Redhill Biopharma Ltd. | -1.063% | -1.063% |
| iShares Core DAX® | -0.552% | 3.281% |
| iShares Nasdaq 100 | -1.415% | 4.535% |
| iShares Nikkei 225® | -0.877% | -1.739% |
| iShares S&P 500 | -0.415% | 3.239% |
According to Marianka what are the pros and cons of Redhill Biopharma Ltd. for the foreseeable future?
Pros
Fair valuation
Good culture
Innovative
Sustainability is important
Very capable Management
Cons
Little Investments for future growth
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Very low/no dividend yield expected
very negative Cash Flow expected
Bad rating
ROE lower than 10% per year
High risks in the balance sheet
Few uniques
Below average Marketposition
Increased challenges to pay loans and raise capital
Growths slower than the competition
high free float
High risks for its business
Very high cyclical dependencies
Little known brand
Outdated or very high risk business model
Comments by Marianka for this prediction
In the thread Redhill Biopharma Ltd. diskutieren
Sell mit Kursziel 0,0